Iguana Healthcare Management’s Amgen AMGN Stock Holding History

Iguana Healthcare Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-50,000	Closed	-$8.2M	–	63
2017 Q1	$8.2M	Hold	50,000	–	–	4.06%	5
2016 Q4	$7.31M	Sell	50,000 -60,000	-55%	-$9.03M	4.37%	5
2016 Q3	$18.4M	Buy	110,000 +75,000	+214%	+$12.7M	3.27%	6
2016 Q2	$5.33M	Hold	35,000	–	–	2.17%	15
2016 Q1	$5.25M	Sell	35,000 -65,000	-65%	-$9.66M	1.92%	17
2015 Q4	$16.2M	Buy	100,000 +35,000	+54%	+$5.5M	5.34%	4
2015 Q3	$8.99M	Buy	65,000 +5,000	+8%	+$788K	3.54%	9
2015 Q2	$9.21M	Buy	+60,000	New	+$9.61M	2.91%	8
2015 Q1	–	Sell	-35,000	Closed	-$5.58M	–	64
2014 Q4	$5.58M	Sell	35,000 -46,500	-57%	-$7.25M	2.69%	10
2014 Q3	$11.4M	Sell	81,500 -1,000	-1%	-$131K	6.12%	3
2014 Q2	$9.77M	Sell	82,500 -21,500	-21%	-$2.49M	4.56%	2
2014 Q1	$12.8M	Buy	104,000 +4,000	+4%	+$485K	5.93%	2
2013 Q4	$11.4M	Buy	+100,000	New	+$11.4M	6.5%	1

Other funds holding AMGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Iguana Healthcare Management's AMGN Position: Q2 2017 in Review

Iguana Healthcare Management sold out of Amgen (AMGN) in Q2 2017, closing a stake of 50,000 shares — an estimated $8.2M sold.

Iguana Healthcare Management first reported a position in AMGN in Q4 2013 and held it in 13 quarters. The position peaked at $18.4M in Q3 2016. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

Iguana Healthcare Management reported no remaining Amgen position as of Q2 2017 after selling out during the quarter.
Iguana Healthcare Management sold 50,000 Amgen shares in Q2 2017, an estimated $8.2M.
Iguana Healthcare Management first reported a position in Amgen in Q4 2013 and held it in 13 quarters.
Iguana Healthcare Management's Amgen position peaked at $18.4M in Q3 2016.
1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Iguana Healthcare Management's 13F filing for Q2 2017, filed 14 Aug 2017.